多股评 | Professional Stock Review | Investor Community

GuocoLand Issues 110M Notes: 2.5% Coupon for Working Capital

52 Browse
GuocoLand Issues 110M Notes: 2.5% Coupon for Working Capital

GuocoLand Issues 110M Notes: 2.5% Coupon for Working Capital

GuocoLand plans to issue notes totaling SGD 110 million, with an annual coupon rate of 2.5%.

The group said in an SGX filing after market close on Monday (June 22) that the notes will be issued by wholly owned subsidiary GLL IHT as part of its SGD 3 billion multi-currency medium-term note program.

Note Terms and Issuance Arrangements

The notes are guaranteed by GuocoLand, expected to be issued around June 30 this year, and will mature on September 30, 2030. Each note has a face value of SGD 250,000, with semi-annual interest payments on March 30 and September 30 each year, starting March 30, 2027.

Underwriter and Use of Proceeds

DBS Bank has been appointed as the sole lead manager and bookrunner for the notes issuance.

The net proceeds from the issuance will be used as working capital for the group and its subsidiaries.

Share Performance

GuocoLand shares closed at SGD 2.18 on Monday, down 0.46%.

Disclaimer

The content of this article is for market analysis, investment knowledge popularization, and personal opinion sharing only, and does not constitute any investment advice. Stock market investment involves risks, please invest cautiously.

More Views

Explore more expert articles

Unveiling the
US Stock AI Computing Intelligence

Unveiling the "Fuel Room" of AI: A Comprehensive Analysis of the US Stock AI Computing Power Industry Chain and Investment Logic

Read More
Policy Becomes the Biggest Variable in AI Computing Power: Export Controls and Sovereign AI Reshape the Valuation Map of the U.S. Compute Industry Chain
US Stock AI Computing Intelligence

Policy Becomes the Biggest Variable in AI Computing Power: Export Controls and Sovereign AI Reshape the Valuation Map of the U.S. Compute Industry Chain

Read More
Is a Higher Dividend Yield Always Better? A Three-Step Beginner's Breakdown of US Dividend Pharma Stocks — How AI Is Rewriting High-Yield Valuation Logic
US Stock Dividend Medical Insight

Is a Higher Dividend Yield Always Better? A Three-Step Beginner's Breakdown of US Dividend Pharma Stocks — How AI Is Rewriting High-Yield Valuation Logic

Read More
Success
Operation completed successfully!